Search Results for: autism

Weekly reads: stem cells for MS, good news x2, extending dog years, Neuralink updates

/ / 2 Comments
stem cells for MS

For about as long as I’ve been writing The Niche, people have been asking about stem cells for MS. There’s a huge need for new therapies. While a chemo-based approach with autologous hematopoietic stem cell transplantation (HSCT) looks to work for certain cases of multiple sclerosis (although not yet approved in the US), other cell […]

Weekly reads: stem cells for MS, good news x2, extending dog years, Neuralink updates Read More »

Review of Docere Clinics run by Harry Adelson including total-body injections

/ / 2 Comments
Amy Killen, Docere Clinic

In today’s post, I reviewed a stem cell clinic firm called Docere Clinics. In my opinion, there are some concerning issues here and reasons for caution. One type of procedure at Docere is particularly surprising and raises risks in my view. What is Docere Clinics? | What kind of stem cells does Docere use? | What they

Review of Docere Clinics run by Harry Adelson including total-body injections Read More »

Weekly reads: stem cell-assisted IVF, Takeda MSC trial, reporters getting stem cells

/ / 1 Comment
stem cell-assisted IVF, Dina Radenkovic, Gameto

There’s been much discussion about issues related to stem cells in the reproductive space such as human embryo models and differentiating stem cells into gametes, but there’s also interest in stem cell-assisted IVF. In this kind of method, stem cells are employed to make tissue cells such as ovarian stromal cells to support production of

Weekly reads: stem cell-assisted IVF, Takeda MSC trial, reporters getting stem cells Read More »

FDA warns Neil Riordan U.S. perinatal firm Signature Biologics

/ / Leave a Comment
Signature Biologics, Neil Riordan

Neil Riordan may be most well-known for running the Panama stem cell clinic called simply enough the Stem Cell Institute, but he also has a U.S. firm Signature Biologics. The Panama  clinic sells unproven umbilical cord cells grown in a lab for a host of medical conditions. I’ve had many concerns about it over the

FDA warns Neil Riordan U.S. perinatal firm Signature Biologics Read More »

Weekly reads: embryonic stem cells, Parkinson’s, Alzheimer’s

/ / 6 Comments
Knoepfler lab stem cells

Early during my postdoc I was primarily interested in the role of Myc genes both in cancer and in stem cells, work that later included embryonic stem cells. These cells are often called ES cells. At first I first started studying N-Myc in neural stem cells using a conditional knockout approach. However, soon after I was

Weekly reads: embryonic stem cells, Parkinson’s, Alzheimer’s Read More »

Stem cell therapy cost in 2024: data & analysis

/ / 4 Comments
stem cell therapy cost

How much does stem cell therapy cost in 2024? How have prices changed? To authoritatively answer these questions now we need data from the present and past along with expert perspectives. Some surprises come up in this new analysis. In this article Intro  | Stem Cell Therapy Cost: $10,000-$20,000 | Why do stem cells cost so much?

Stem cell therapy cost in 2024: data & analysis Read More »

Weekly reads: reprogramming hearing loss, heart disease, eye drops, sickle cell

/ / Leave a Comment
Regener-Eyes, eye drops

It’s mostly been a week of good and encouraging news in the regenerative medicine space including with gene therapies maybe with the exception of some eye drops warnings (more below). There’s realistic hope for an approved sickle cell disease soon. I also see some long-term positive news on hearing loss research. Hematopoietic stem cell transplant

Weekly reads: reprogramming hearing loss, heart disease, eye drops, sickle cell Read More »

Weekly reads: FDA nod on new cell therapy, gray hair, pong-playing cells

/ / Leave a Comment

It’s a big challenge to get a cell therapy approved by the FDA and if you look at my list of FDA-approved stem cell therapies, it’s not as long as we might hope. FDA OK on cell therapy from Gamida Cell For this reason, it was excellent news to see that the FDA approved a

Weekly reads: FDA nod on new cell therapy, gray hair, pong-playing cells Read More »

Weekly reads: Sarepta, epigenomics, FDA on eyedrops

/ / Leave a Comment
Sarepa CEO interview.

The biotech Sarepta has had a complicated go of it with the FDA sometimes related to their Duchenne muscular dystrophy (DMD) gene therapy efforts. In late 2016 I wrote about how there was some controversy as the FDA approved the Sarepta drug eteplirsen (Exondys 51) also for DMD, going against an advisory panel that had

Weekly reads: Sarepta, epigenomics, FDA on eyedrops Read More »

Does NurOwn from BrainStorm Cell Therapeutics still provide hope for ALS?

/ / Leave a Comment
Chaim Lebovits, CEO of BrainStorm Cell Therapeutics.

What is the cell therapy for ALS called NurOwn? How strong is its potential as a treatment for ALS? I’ve been following the biotech BrainStorm Cell Therapeutics for many years. Patients keep asking me about NurOwn ALS prospects. They’re looking for hope. Today’s post is a close look at NurOwn and at BrainStorm as a

Does NurOwn from BrainStorm Cell Therapeutics still provide hope for ALS? Read More »